Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hans Carl Hasselbalch (Hans Hasselbalch, Hans C Hasselbalch)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 32

Top Venues

European journal of haematology

Blood advances

Cancer medicine

Clinical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Hans Carl Hasselbalch, Vibe Skov, Lasse Kjaer, Morten Kranker Larsen
Proof of concept of triple COMBI therapy to prohibit MPN progression to AML. British journal of haematology (2023)
Vibe Skov, Mads Thomassen, Lasse Kjaer, Morten Kranker Larsen, Trine A Knudsen, Christina Ellervik, Torben A Kruse, Hans Carl Hasselbalch
Whole blood transcriptional profiling reveals highly deregulated atherosclerosis genes in Philadelphia-chromosome negative myeloproliferative neoplasms. European journal of haematology (2023)
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiří Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian, null null
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment. Leukemia (2023)
Daniel Tuyet Kristensen, Andreas Kiesbye Øvlisen, Lasse Hjort Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Hasselbalch, Tarec C El-Galaly, Anne Stidsholt Roug
Use of statins and risk of myeloproliferative neoplasms - a Danish nationwide case-control study. Blood advances (2023)
Camilla Nordheim Solli, Sandra Chamat-Hedemand, Hanne Elming, Anh Ngo, Lasse Kjaer, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Hans Carl Hasselbalch, Niels Eske Bruun
High JAK2V617F variant allele frequency is associated with coronary artery but not aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms. European journal of haematology (2023)
Marie Hvelplund Kristiansen, Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Christina Ellervik, Hans Carl Hasselbalch, Troels Wienecke
JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study. Blood advances (2023)
Hans Carl Hasselbalch, Peter Junker, Vibe Skov, Lasse Kjær, Trine Alma Knudsen, Morten Kranker Larsen, Morten Orebo Holmström, Mads Hald Andersen, Christina Jensen, Morten A Karsdal, Nicholas Willumsen
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms. Cancers 15 (17) (2023)
Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Lee O'Brien Andersen, Morten Kranker Larsen, Lasse Kjaer, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Christina Ellervik, Lars Rønn Olsen, Hans Carl Hasselbalch, Jens Jørgen Elmer Christensen, Xiaohui Chen Nielsen
Pronounced gut microbiota signatures in patients with JAK2V617F- positive essential thrombocythemia. Microbiology spectrum (2023)
Sarah Friis Christensen, Lise Skovgaard Svingel, Anders Kjaersgaard, Anna Stenling, Bianka Darvalics, Björn Paulsson, Christen Lykkegaard Andersen, Christian Fynbo Christiansen, Jesper Stentoft, Jørn Starklint, Marianne Tang Severinsen, Mette Borg Clausen, Morten Hagemann Hilsøe, Hans Carl Hasselbalch, Henrik Frederiksen, Ellen Margrethe Mikkelsen, Marie Bak
Healthcare resource utilization in patients with myeloproliferative neoplasms: A Danish nationwide matched cohort study. European journal of haematology 109 (5) (2022)
Mathieu Gigoux, Morten Orebo Holmström, Roberta Zappasodi, Joseph J Park, Stephane Pourpe, Cansu Cimen Bozkus, Levi M B Mangarin, David Redmond, Svena Verma, Sara Schad, Mariam M George, Divya Venkatesh, Arnab Ghosh, David Hoyos, Zaki Molvi, Baransel Kamaz, Anna E Marneth, William Duke, Matthew J Leventhal, Max Jan, Vincent T Ho, Gabriela S Hobbs, Trine Alma Knudsen, Vibe Skov, Lasse Kjær, Thomas Stauffer Larsen, Dennis Lund Hansen, R Coleman Lindsley, Hans Carl Hasselbalch, Jacob H Grauslund, Thomas L Lisle, Özcan Met, Patrick Wilkinson, Benjamin Greenbaum, Manuel A Sepulveda, Timothy A Chan, Raajit Rampal, Mads Hald Andersen, Omar Abdel-Wahab, Nina Bhardwaj, Jedd D Wolchok, Ann Mullally, Taha Merghoub
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Science translational medicine 14 (649) (2022)
Morten Kranker Larsen, Vibe Skov, Lasse Kjaer, Natascha A Møller-Palacino, Rasmus K Pedersen, Morten Andersen, Johnny T Ottesen, Sabrina Cordua, Henrik E Poulsen, Morten Dahl, Trine A Knudsen, Christina Schjellerup Eickhardt-Dalbøge, Steffen Koschmieder, Kasper M Pedersen, Yunus Çolak, Stig Egil Bojesen, Børge G Nordestgaard, Thomas Stiehl, Hans Carl Hasselbalch, Christina Ellervik
Clonal haematopoiesis of indeterminate potential and impaired kidney function-A Danish general population study with 11 years follow-up. European journal of haematology 109 (5) (2022)
Jean-Jacques Kiladjian, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiří Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans Carl Hasselbalch, Robert Kralovics, Heinz Gisslinger, null null
Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b. Leukemia 36 (5) (2022)
Marc J B Dam, Rasmus Kristoffer Pedersen, Trine Alma Knudsen, Morten Andersen, Christina Ellervik, Morten Kranker Larsen, Lasse Kjaer, Vibe Skov, Hans Carl Hasselbalch, Johnny T Ottesen
A novel integrated biomarker index for the assessment of hematological responses in MPNs during treatment with hydroxyurea and interferon-alpha2. Cancer medicine (2022)
Hans Carl Hasselbalch, Vibe Skov, Lasse Kjær, Morten Kranker Larsen, Trine Alma Knudsen, Marko Lucijanic, Rajko Kusec
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives. Cancers 14 (22) (2022)
Christina Schjellerup Eickhardt-Dalbøge, Anna Cäcilia Ingham, Lee O'Brien Andersen, Henrik Vedel Nielsen, Kurt Fuursted, Christen Rune Stensvold, Morten Kranker Larsen, Lasse Kjær, Sarah Friis Christensen, Trine Alma Knudsen, Vibe Skov, Christina Ellervik, Lars Rønn Olsen, Hans Carl Hasselbalch, Xiaohui Chen Nielsen, Jens Jørgen Elmer Christensen
The Gut Microbiota in Patients with Polycythemia Vera is Distinct from that of Healthy Controls and Varies by Treatment. Blood advances (2022)
Arthur E Frankel, Renuka Reddy, Kayla R DeSuza, Khaled Deeb, Aaron F Carlin, Davey Smith, Yushuang Xie, Eknath Naik, Richard T Silver, Hans Carl Hasselbalch
Response to pegylated interferon in a COVID-19-positive elderly woman with primary myelofibrosis treated with ruxolitinib. Clinical case reports 9 (4) (2021)
Marc J B Dam, Rasmus K Pedersen, Trine A Knudsen, Morten Andersen, Vibe Skov, Lasse Kjaer, Hans Carl Hasselbalch, Johnny T Ottesen
Data-driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis. European journal of haematology 107 (6) (2021)
Trine Alma Knudsen, Vibe Skov, Kristen E Stevenson, Lillian Werner, William Duke, Charles Laurore, Christopher James Gibson, Anwesha Nag, Aaron R Thorner, Bruce Wollison, Dennis Lund Hansen, Christina Ellervik, Daniel El Fassi, Karin de Stricker, Lukas Frans Ocias, Mette Brabrand, Ole Weis Bjerrum, Ulrik Overgaard, Mikael Frederiksen, Thomas Kristensen, Torben Kruse, Mads Thomassen, Torben Mourits-Andersen, Marianne Tang Severinsen, Jesper Stentoft, Jørn Starklint, Donna Neuberg, Lasse Kjaer, Thomas S Larsen, Hans Carl Hasselbalch, R Coleman Lindsley, Ann Mullally
Genomic Profiling of a Randomized Trial of Interferon-α versus Hydroxyurea in MPN Reveals Mutation-Specific Responses. Blood advances (2021)
Arthur E Frankel, Wai C Yip, Eknath Naik, Hans Carl Hasselbalch
Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus. Clinical case reports 9 (6) (2021)
Hans Carl Hasselbalch, Vibe Skov, Lasse Kjær, Torben L Sørensen, Christina Ellervik, Troels Wienecke
Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer's disease: evidences and perspectives. Journal of neuroinflammation 17 (1) (2020)
Rasmus Kristoffer Pedersen, Morten Andersen, Trine Alma Knudsen, Zamra Sajid, Johanne Gudmand-Hoeyer, Marc J B Dam, Vibe Skov, Lasse Kjaer, Christina Ellervik, Thomas Stauffer Larsen, Dennis Lund Hansen, Niels Pallisgaard, Hans Carl Hasselbalch, Johnny T Ottesen
Data-driven analysis of JAK2V617F kinetics during interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms. Cancer medicine 9 (6) (2020)
Sabrina Cordua, Lasse Kjaer, Vibe Skov, Niels Pallisgaard, Hans Carl Hasselbalch, Christina Ellervik
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population. Blood 134 (5) (2019)
Nimesh A Jayasuriya, Alisa D Kjaergaard, Kasper Mønsted Pedersen, Anders Lindholm Sørensen, Marie Bak, Morten K Larsen, Børge Grønne Nordestgaard, Stig Egil Bojesen, Yunus Çolak, Vibe Skov, Lasse Kjaer, Janne Schurmann Tolstrup, Hans Carl Hasselbalch, Christina Ellervik
Smoking, blood cells and myeloproliferative neoplasms: meta-analysis and Mendelian randomization of 2·3 million people. British journal of haematology 189 (2) (2019)
Anders Lindholm Sørensen, Mads Emil Bjørn, Caroline H Riley, Morten Holmstrøm, Mads Hald Andersen, Inge Marie Svane, Stine Ulrik Mikkelsen, Vibe Skov, Lasse Kjaer, Hans Carl Hasselbalch, Claus H Nielsen
B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatment. European journal of haematology 103 (4) (2019)
Vardan Nersesjan, Kristoffer A Zervides, Anders Lindholm Sørensen, Lasse Kjaer, Vibe Skov, Hans Carl Hasselbalch
The red blood cell count and the erythrocyte sedimentation rate in the diagnosis of polycythaemia vera. European journal of haematology 104 (1) (2019)
Morten Orebo Holmström, Hans Carl Hasselbalch, Mads Hald Andersen
Neo-antigen specific memory T-cell responses in healthy individuals. Oncoimmunology 8 (7) (2019)
Stine Ulrik Mikkelsen, Lasse Kjaer, Mads Emil Bjørn, Trine Alma Knudsen, Anders Lindholm Sørensen, Christen Bertel Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Daniel El Fassi, Torben A Kruse, Thomas Stauffer Larsen, Hans Torben Mourits-Andersen, Claus Henrik Nielsen, Niels Pallisgaard, Mads Thomassen, Vibe Skov, Hans Carl Hasselbalch
Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis. Cancer medicine 7 (8) (2018)
Hans Carl Hasselbalch, Morten Orebo Holmström
Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure? Seminars in immunopathology 41 (1) (2018)
Kasper Mønsted Pedersen, Marie Bak, Anders L Sørensen, Ann-Dorthe Zwisler, Christina Ellervik, Morten K Larsen, Hans Carl Hasselbalch, Janne S Tolstrup
Smoking is associated with increased risk of myeloproliferative neoplasms: A general population-based cohort study. Cancer medicine 7 (11) (2018)
Mia Aaboe Jørgensen, Morten Orebo Holmström, Evelina Martinenaite, Caroline Hasselbalch Riley, Hans Carl Hasselbalch, Mads Hald Andersen
Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation. Oncoimmunology 7 (9) (2018)
Hans Carl Hasselbalch
Molecular profiling as a novel tool to predict response to interferon-α2 in MPNs: The proof of concept in early myelofibrosis. Cancer 123 (14) (2017)
Morten Andersen, Zamra Sajid, Rasmus K Pedersen, Johanne Gudmand-Hoeyer, Christina Ellervik, Vibe Skov, Lasse Kjær, Niels Pallisgaard, Torben A Kruse, Mads Thomassen, Jesper Troelsen, Hans Carl Hasselbalch, Johnny T Ottesen
Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development. PloS one 12 (8) (2017)

Hans Carl Hasselbalch.css-eqlu8i{font-size:small;padding-left:4px;} (Hans Hasselbalch, Hans C Hasselbalch)

Publication Activity (10 Years)

Top Topics

Top Venues

Hans Carl Hasselbalch (Hans Hasselbalch, Hans C Hasselbalch)